• CJC-1295 with Ipamorelin is a synergistic peptide combination
• designed to stimulate natural growth hormone (GH) release
• safely and effectively.
• CJC-1295 promotes a steady, long-acting increase in GH by stimulating GHRH receptors, while
• Ipamorelin specifically targets ghrelin receptors for rapid GH release without significantly
• affecting appetite or cortisol levels.
• Together, this duo enhances lean muscle growth, fat metabolism, recovery, and anti-aging
• benefits, making it one of the most popular peptide therapies for overall performance, vitality,
• and longevity.

Mechanism of Action:

• CJC-1295: Stimulates pituitary GHRH receptors for sustained GH release
• Increases circulating IGF-1 levels to support tissue repair and muscle growth
• Ipamorelin: Selective ghrelin receptor agonist promoting GH pulses
• Minimal effect on appetite, cortisol, or prolactin, offering a safer profile
• Combined Effect: Mimics physiologic GH secretion patterns (pulsatile + sustained)
• Enhances recovery, fat burning, and cellular regeneration

Ideal For:

• Patients seeking growth hormone optimization without synthetic GH injections
• Anti-aging and longevity support
• Improved lean muscle development and fat metabolism
• Faster recovery from training or injury
• Enhanced sleep quality, energy, and cognitive performance

Dosage & Protocols:

• Typical SubQ Dose: 0.1–0.2 mL (200–400 mcg of each peptide) per injection
• Frequency: 1–2 times daily, often in the evening before sleep or post-exercise
• Duration: 8–12 weeks, with provider monitoring and reassessment
• Dosage should always be tailored under clinical supervision

Common Injection Sites:

SubQ: Lower abdomen, thigh, or triceps region